CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dietrich, M.
Right arrow Articles by Packer, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dietrich, M.
Right arrow Articles by Packer, L.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 7-13, January 2002
© 2002 American Association for Cancer Research

Antioxidant Supplementation Decreases Lipid Peroxidation Biomarker F2-isoprostanes in Plasma of Smokers1

Marion Dietrich2, Gladys Block2, Mark Hudes, Jason D. Morrow, Edward P. Norkus, Maret G. Traber, Carroll E. Cross and Lester Packer

School of Public Health [M. D., G. B.] and Department of Nutritional Sciences [M. H.], University of California, Berkeley, California 94720-7360; Vanderbilt University, Division of Clinical Pharmacology, Nashville, Tennessee 37232-6602 [J. D. M.]; Department of Biomedical Research, Our Lady of Mercy Medical Center, Bronx, New York 10466-2697 [E. P. N.]; University of California Davis School of Medicine, Sacramento, California 95817 [M. G. T., C. E. C.]; Department of Nutrition and Food Management, Linus Pauling Institute, Oregon State University, Corvallis, Oregon 97331-6512 [M. G. T.]; and Department of Molecular Pharmacology and Toxicology, University of Southern California, Los Angeles, California 90089-9121 [L. P.]

Free radicals in cigarette smoke (CS) cause oxidative damage to proteins, DNA, and lipids, contributing to the pathobiology of atherosclerosis, heart disease, and cancer. In vitro studies have shown that antioxidants quench free radicals and ameliorate certain aspects of biomolecular damage caused by CS. It is hypothesized that a combination of antioxidants is more effective than a single antioxidant, due to their interactions. To investigate whether supplemental antioxidants reduce CS-related lipid peroxidation in vivo and whether they are more effective in combination, we conducted an intervention study in smokers. In a randomized double-blind placebo-controlled trial, we investigated whether vitamin C or an antioxidant mixture containing vitamin C, {alpha}-lipoic acid, and vitamin E decreases plasma F2-isoprostane levels, an index of oxidant stress, in smokers. Plasma of 126 smokers (mean age, 46 years; age range, 20–78 years) was analyzed for F2-isoprostanes at baseline and after intervention with antioxidants and placebo. In smokers with a body mass index (BMI) above the median, 2 months of daily supplementation with 500 mg of vitamin C decreased plasma F2-isoprostane levels by 28.8 pmol/liter when compared with the placebo group (P = 0.001); levels in the mixture group were 7.45 pmol/liter lower after treatment, but this difference was not statistically significant (P = 0.14). There was no treatment effect in smokers with a low BMI. BMI was significantly positively associated with plasma F2-isoprostane levels (trend P = 0.001). Antioxidants decrease smoking-related lipid peroxidation markers of oxidative stress in humans with high BMI. Our results do not indicate that an antioxidant combination is more effective than vitamin C alone. The intake of antioxidants may help prevent smoking-related diseases. Smoking cessation should still be considered the most effective way to prevent smoking-related diseases.




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
W. Yan, G. D. Byrd, and M. W. Ogden
Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS/MS
J. Lipid Res., July 1, 2007; 48(7): 1607 - 1617.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
G Scherer, M Urban, H-W Hagedorn, S Feng, R D Kinser, M Sarkar, Q Liang, and H-J Roethig
Determination of two mercapturic acids related to crotonaldehyde in human urine: influence of smoking
Human and Experimental Toxicology, January 1, 2007; 26(1): 37 - 47.
[Abstract] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. Dietrich, M. G Traber, P. F Jacques, C. E Cross, Y. Hu, and G. Block
Does {gamma}-Tocopherol Play a Role in the Primary Prevention of Heart Disease and Cancer? A Review.
J. Am. Coll. Nutr., August 1, 2006; 25(4): 292 - 299.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
Y. Hu, G. Block, E. P Norkus, J. D Morrow, M. Dietrich, and M. Hudes
Relations of glycemic index and glycemic load with plasma oxidative stress markers
Am. J. Clinical Nutrition, July 1, 2006; 84(1): 70 - 76.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Ahn, S. Nowell, S. E. McCann, J. Yu, L. Carter, N. P. Lang, F. F. Kadlubar, L. D. Ratnasinghe, and C. B. Ambrosone
Associations between Catalase Phenotype and Genotype: Modification by Epidemiologic Factors.
Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1217 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
E. F. M. Wouters
Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 26 - 33.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
I. S. Young
Oxidative Stress and Vascular Disease: Insights from Isoprostane Measurement
Clin. Chem., January 1, 2005; 51(1): 14 - 15.
[Full Text] [PDF]


Home page
FASEB J.Home page
P. MONTUSCHI, P. J. BARNES, and L. J. ROBERTS II
Isoprostanes: markers and mediators of oxidative stress
FASEB J, December 1, 2004; 18(15): 1791 - 1800.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Micheletta, S. Natoli, and L. Iuliano
Supplemented {alpha}-Tocopherol Apparently Does Not Enter the Plaque Compartment
Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): e141 - e142.
[Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
G. Block, C. Jensen, M. Dietrich, E. P. Norkus, M. Hudes, and L. Packer
Plasma C-Reactive Protein Concentrations in Active and Passive Smokers: Influence of Antioxidant Supplementation
J. Am. Coll. Nutr., April 1, 2004; 23(2): 141 - 147.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. E Upritchard, C. R. Schuurman, A. Wiersma, L. B. Tijburg, S. A. Coolen, P. J Rijken, and S. A Wiseman
Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, nonsmoking adults
Am. J. Clinical Nutrition, November 1, 2003; 78(5): 985 - 992.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. V. Higdon and B. Frei
Obesity and Oxidative Stress: A Direct Link to CVD?
Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 365 - 367.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. F. Keaney Jr, M. G. Larson, R. S. Vasan, P. W.F. Wilson, I. Lipinska, D. Corey, J. M. Massaro, P. Sutherland, J. A. Vita, and E. J. Benjamin
Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study
Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 434 - 439.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
S. J. Padayatty, A. Katz, Y. Wang, P. Eck, O. Kwon, J.-H. Lee, S. Chen, C. Corpe, A. Dutta, S. K Dutta, et al.
Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention
J. Am. Coll. Nutr., February 1, 2003; 22(1): 18 - 35.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. Dietrich, G. Block, E. P Norkus, M. Hudes, M. G Traber, C. E Cross, and L. Packer
Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase {gamma}-tocopherol in vivo after adjustment for dietary antioxidant intakes
Am. J. Clinical Nutrition, January 1, 2003; 77(1): 160 - 166.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
G. Block, M. Dietrich, E. P. Norkus, J. D. Morrow, M. Hudes, B. Caan, and L. Packer
Factors Associated with Oxidative Stress in Human Populations
Am. J. Epidemiol., August 1, 2002; 156(3): 274 - 285.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.